PHILADELPHIA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinicalstage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences: Canaccord Genuity 44th Annual Growth Conference Format: Management will participate in a presentation and investor meetings Date: Tuesday, August 13, 2024 Presentation Time: 8:00 a.m. ET Location: Boston, MA 15th Ann ...